MCEMP1 is an adaptor for KIT receptor for mast cell proliferation

MCEMP1 是用于肥大细胞增殖的 KIT 受体的接头

基本信息

  • 批准号:
    10214740
  • 负责人:
  • 金额:
    $ 10.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2023-03-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract: Mast Cell Expressed Membrane Protein 1 (MCEMP1) is a transmembrane protein highly expressed in lung-resident mast cells. Interestingly, MCEMP1 is one of the top inducible genes in several inflammatory lung diseases including asthma. Indeed, asthma patients at exacerbation stage show higher expression of MCEMP1 than asthma patients at recovery stage. However, a cellular function of MCEMP1 in mast cells and a pathological role of MCEMP1 in asthma are entirely unknown. In preliminary study, I discovered that MCEMP1 interacted with KIT receptor on the surface of mast cells. While an immunoglobulin E (IgE)–FcεRI complex activates mast cells to induce degranulation, KIT surface receptor and its ligand stem cell factor (SCF) are critical for the proliferation of mast cells. Upon SCF stimulation, peritoneal mast cells from Mcemp1–/– mice showed decreased proliferation compared to those from wild-type mice. In addition, SCF-mediated in vivo expansion of lung mast cells was significantly reduced in Mcemp1–/– mice. Importantly, Mcemp1–/– mice showed reduced lung inflammation in asthma model. Based on these, I hypothesize that MCEMP1 is a critical adaptor for KIT receptor signaling that promotes SCF-mediated mast cell proliferation and contributes to asthma exacerbation. Herein, I seek to address the following: (i) a cellular role of MCEMP1 in SCF-induced mast cell expansion by potentiating KIT receptor signaling. (ii) a pathological role of MCEMP1-mediated mast cell expansion in the progression of severe asthma. (iii) Lastly, I will develop therapeutic approach to inhibit the pathologic function of MCEMP1 in asthma. Collectively, this study will not only define the pathobiological role of MCEMP1 in mast cell expansion and asthma progression, but also provide novel insight into a new therapeutic target for asthma. This award will support a new molecular mechanism of mast cell proliferation and an important mechanistic finding in the field of asthma.
项目概要/摘要: 肥大细胞表达膜蛋白1(MCEMP 1)是一种在肥大细胞中高度表达的跨膜蛋白。 肺内肥大细胞有趣的是,MCEMP 1是几种炎症性肺组织中最常见的诱导基因之一, 包括哮喘在内的疾病。事实上,哮喘患者在急性发作期表现出更高的MCEMP 1表达, 哮喘患者在恢复期然而,MCEMP 1在肥大细胞中的细胞功能和病理性的 MCEMP 1在哮喘中的作用完全未知。在初步研究中,我发现MCEMP 1与 与肥大细胞表面的KIT受体结合。免疫球蛋白E(IgE)-FcεRI复合物激活肥大细胞, 细胞诱导脱粒,KIT表面受体及其配体干细胞因子(SCF)是关键的, 肥大细胞增殖。SCF刺激后,Mcemp 1-/-小鼠的腹腔肥大细胞显示减少, 与野生型小鼠相比,此外,SCF介导的肺肥大细胞的体内扩增, Mcemp 1-/-小鼠中细胞显著减少。重要的是,Mcemp 1-/-小鼠表现出减少的肺 哮喘模型中炎症。基于这些,我假设MCEMP 1是KIT的关键适配器 促进SCF介导的肥大细胞增殖并导致哮喘的受体信号传导 加重在此,我试图解决以下问题:(i)MCEMP 1在SCF诱导的肥大细胞中的细胞作用 通过增强KIT受体信号传导进行扩增。(ii)MCEMP 1介导的肥大细胞的病理作用 严重哮喘的进展。(iii)最后,我将开发治疗方法来抑制 MCEMP 1在哮喘中的病理作用总的来说,这项研究不仅将确定的病理生物学作用, MCEMP 1在肥大细胞扩增和哮喘进展中的作用,也为新的治疗方法提供了新的见解。 哮喘的目标该奖项将支持肥大细胞增殖的新分子机制和重要的 在哮喘领域的机械发现。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Youn Jung Choi其他文献

Youn Jung Choi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Youn Jung Choi', 18)}}的其他基金

MCEMP1 is an adaptor for KIT receptor for mast cell proliferation
MCEMP1 是用于肥大细胞增殖的 KIT 受体的接头
  • 批准号:
    10375551
  • 财政年份:
    2021
  • 资助金额:
    $ 10.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了